Bigtincan

Belkins
Bigtincan (ASX:BTH) helps sales and service teams increase win rates and customer satisfaction. The company’s mobile, AI-powered sales enablement automation platform features the industry’s premier user experience that empowers reps to more effectively engage with customers and prospects and encourages team-wide adoption. In addition to seven of the Fortune 10 companies, leading brands including AT&T, ThermoFisher, Merck, ANZ Bank and others rely on Bigtincan to enhance sales productivity at every customer interaction. With global sales and marketing headquartered in Boston, Bigtincan also has offices across EMEA, Australia and Asia. To discover more about how your organization can benefit from the Bigtincan Hub platform.

C-Suite On Deck

Patrick Welch, President and CMO at Bigtincan is a top performing senior executive with 22 years’ experience managing, bringing to market and selling innovative software management solutions to various high value market segments.

Patrick is an inspirational executive...

Events

Related News

BUSINESS INSIGHTS

COEUS HOLDINGS ANNOUNCES PARTNERSHIP WITH INSIGHT CONSULTING GROUP (ICG) TO ADDRESS THE HEALTHCARE INDUSTRY’S CHANGING RESEARCH AND INSIGHT LANDSCAPE

September 18, 2021

news image

COEUS Holdings, LLC, and its subsidiaries, together a leading boutique life sciences technology and consulting firm, today announced that it has entered a partnership with Insight Consulting Group (ICG). The partnership seeks to bridge the gaps between payers, healthcare providers, and consumers by developing insights and strategies that are reflective of today’s integrated needs. The partnership will produce and apply comprehensive insights to inform strategy that could advance access to ...

Read More

BUSINESS INSIGHTS

ASYMCHEM AND LANOVA MEDICINES ENTER INTO PARTNERSHIP AGREEMENT, EXPANDING BIOLOGICAL CAPABILITIES

September 17, 2021

news image

Asymchem today announced a strategic partnership agreement to provide LaNova Medicines with one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration. The collaboration between Asymchem and LaNova will include small molecule drugs, monoclonal antibodies, double antibodies, ADC projects and potentially other R&D and production initiatives. This partnership will take full advantage of Asymchem's recently co...

Read More

BUSINESS INSIGHTS

CEM CORPORATION AND AMBIOPHARM ENTER INTO US PARTNERSHIP FOR GMP PEPTIDE PRODUCTION

September 16, 2021

news image

CEM Corporation and AmbioPharm, Inc. are pleased to announce the formation of a partnership to produce GMP peptides for the global market. The partnership includes the exclusive 1Use of CEM's microwave peptide synthesis technology on a large scale for the production of GMP peptides up to several kilograms using its own scalable reactors. The main advantages of this new relationship are the extremely short production times, the ability to efficiently produce more difficult peptide sequences, ...

Read More

BUSINESS INSIGHTS

September 18, 2021

news image

COEUS HOLDINGS ANNOUNCES PARTNERSHIP WITH INSIGHT CONSULTING GROUP (ICG) TO ADDRESS THE HEALTHCARE INDUSTRY’S CHANGING RESEARCH AND INSIGHT LANDSCAPE

COEUS Holdings, LLC, and its subsidiaries, together a leading boutique life sciences technology and consulting firm, today announced that it has entered a partnership with Insight Consulting Group (ICG). The partnership seeks to bridge the gaps between payers, healthcare providers, and consumers by developing insights and strategies that are reflective of today’s integrated needs. The partnership will produce and apply comprehensive insights to inform strategy that could advance access to ...

Read More

BUSINESS INSIGHTS

September 17, 2021

news image

ASYMCHEM AND LANOVA MEDICINES ENTER INTO PARTNERSHIP AGREEMENT, EXPANDING BIOLOGICAL CAPABILITIES

Asymchem today announced a strategic partnership agreement to provide LaNova Medicines with one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration. The collaboration between Asymchem and LaNova will include small molecule drugs, monoclonal antibodies, double antibodies, ADC projects and potentially other R&D and production initiatives. This partnership will take full advantage of Asymchem's recently co...

Read More

BUSINESS INSIGHTS

September 16, 2021

news image

CEM CORPORATION AND AMBIOPHARM ENTER INTO US PARTNERSHIP FOR GMP PEPTIDE PRODUCTION

CEM Corporation and AmbioPharm, Inc. are pleased to announce the formation of a partnership to produce GMP peptides for the global market. The partnership includes the exclusive 1Use of CEM's microwave peptide synthesis technology on a large scale for the production of GMP peptides up to several kilograms using its own scalable reactors. The main advantages of this new relationship are the extremely short production times, the ability to efficiently produce more difficult peptide sequences, ...

Read More